Luminus Management LLC Global Blood Therapeutics, Inc. Transaction History

Luminus Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$45.35 - $57.91 $17.6 Million - $22.4 Million	-387,230 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$52.6 - $63.29 $20.4 Million - $24.5 Million	387,230 New	387,230 $20.4 Million
Q1 2019 May 15, 2019	SELL	$39.99 - $53.48 $2.5 Million - $3.34 Million	-62,524 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$31.54 - $46.67 $1.97 Million - $2.92 Million	62,524 New	62,524 $2.57 Million

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Luminus Management LLC, based on Form 13F filings with the SEC.

Stay updated on Luminus Management LLC with notifications on news.